Connect Bropharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Connect Bropharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Connect Bropharma Today - Breaking & Trending Today

5-Year Safety Data From Upadacitinib Trials Reported

Published: January 3, 2024

Upadacitinib trials in atopic dermatitis have included diverse patient groups with varying risk factors, according to Dr Christopher Bunick.

Source: medscape.com

Related Topics:

United StatesUnited KingdomYale UniversityNew HavenLeo PharmaEli LillyChristopherg BunickUpadacitinib RinvoqDrug AdministrationRevolutionizing Atopic Dermatitis VirtualOrtho DermatologicsConnect BropharmaAtopic DermatitisAtopic EczemaHerpes ZosterAdolescent MedicineAdolescent HealthCv RiskCardiovascular RiskV Risk FactorsCardiovascular Risk FactorsCardiovascular Risk ManagementBody Mass IndexClinical ResearchClinical Trials